NASDAQ •
Healthcare •
Biotechnology •
Quote as of 08/20/2026 12:55
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization174.11 mln
Float82.35 mln
Earnings Date10/29/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-3.39
Reliable
1-Year Forecast
6.50
Transformational upside
Relative Strength
82
/ 100
Strongly outperforming
Debt / Equity
2.20
Very high leverage
ROE
-69.54
Deeply negative
Business Description
Codexis is a biotechnology company based in Redwood City, California, that uses its proprietary enzyme engineering technology to help manufacturers produce therapeutic drugs more efficiently. Its platform is used to design and improve enzymes that support the large-scale production of RNA-based medicines, among other applications. The company operates across North America, Europe, the Middle East, Asia, and beyond, and works with partners such as Pfizer and Aldevron under licensing agreements.
